Fei Dong Selected Research

Fei Dong Research Topics

Disease

34	Neoplasms (Cancer) 03/2024 - 02/2004
8	Inflammation (Inflammations) 01/2024 - 04/2012
8	Neoplasm Metastasis (Metastasis) 12/2020 - 09/2008
7	Multiple Myeloma 02/2024 - 12/2014
6	Pain (Aches) 10/2023 - 04/2012
5	Leukemia 04/2024 - 05/2015
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2024 - 02/2004
4	Lymphoma (Lymphomas) 04/2024 - 02/2004
4	Infections 04/2024 - 01/2018
4	Fibrosis (Cirrhosis) 01/2024 - 01/2021
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2023 - 01/2017
4	Chromosome Aberrations (Chromosome Abnormalities) 02/2023 - 06/2017
4	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2018
4	Prostatic Neoplasms (Prostate Cancer) 07/2010 - 03/2008
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 04/2018
3	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2017
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 12/2018
3	Necrosis 01/2021 - 05/2018
3	Glioma (Gliomas) 01/2020 - 12/2017
3	Carcinoma (Carcinomatosis) 01/2020 - 11/2016
3	Adenocarcinoma of Lung 03/2019 - 12/2017
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2017 - 11/2015
3	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 12/2007 - 02/2004
2	Rheumatoid Arthritis 10/2023 - 02/2014
2	Systemic Scleroderma (Systemic Sclerosis) 10/2023 - 01/2022
2	Mycoses (Diseases, Fungus) 04/2023 - 12/2018
2	Anemia 02/2023 - 01/2019
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 12/2016
2	Hyperalgesia 01/2020 - 04/2015
2	Turcot syndrome 01/2019 - 12/2018
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2019 - 12/2018
2	Adenocarcinoma 04/2016 - 06/2012
2	Hypersensitivity (Allergy) 04/2015 - 11/2012
2	Hepatocellular Carcinoma (Hepatoma) 09/2014 - 02/2009
1	Residual Neoplasm 05/2024
1	Osteoporosis 05/2024
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2024
1	Hodgkin Disease (Hodgkin's Disease) 04/2024
1	Febrile Neutropenia 04/2024
1	Emphysema 02/2024
1	Chronic Obstructive Pulmonary Disease (COPD) 02/2024
1	Myxoma (Myxomas) 11/2023
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2023
1	Dyspnea (Shortness of Breath) 10/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2023
1	Cough 10/2023

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 09/2021 - 11/2016
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2004
5	RNA (Ribonucleic Acid)IBA 02/2024 - 11/2007
5	Proteins (Proteins, Gene)FDA Link 10/2023 - 04/2016
4	NucleotidesIBA 01/2022 - 06/2017
3	Therapeutic UsesIBA 04/2024 - 01/2022
3	Messenger RNA (mRNA)IBA 02/2024 - 03/2019
3	Bortezomib (Velcade)FDA Link 01/2023 - 06/2017
3	Rituximab (Mabthera)FDA Link 01/2022 - 08/2015
3	CytokinesIBA 01/2022 - 04/2012
2	GlucocorticoidsIBA 05/2024 - 10/2023
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2024 - 08/2015
2	CateninsIBA 11/2023 - 01/2021
2	Carbon MonoxideIBA 10/2023 - 01/2019
2	MycotoxinsIBA 04/2023 - 10/2016
2	Lactic Acid (Lactate)FDA LinkGeneric 02/2023 - 12/2016
2	Lenalidomide (CC 5013)FDA Link 01/2023 - 01/2022
2	Chimeric Antigen ReceptorsIBA 05/2022 - 01/2019
2	CollagenIBA 01/2022 - 10/2018
2	Immune Checkpoint InhibitorsIBA 11/2020 - 01/2020
2	Codon (Codons)IBA 01/2020 - 12/2017
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2019 - 12/2016
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2019 - 01/2018
2	TristetraprolinIBA 03/2019 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 05/2018 - 01/2017
2	Anaplastic Lymphoma KinaseIBA 02/2018 - 04/2016
2	CCAAT-Enhancer-Binding ProteinsIBA 11/2017 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 11/2017 - 11/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2015 - 12/2007
2	Capsaicin (Zostrix)FDA Link 04/2015 - 04/2012
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2015 - 01/2015
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 09/2013 - 11/2012
1	pegylated granulocyte colony-stimulating factorIBA 04/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2024
1	nuclear pore complex protein 98IBA 03/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2024
1	ixazomibIBA 02/2024
1	Small Cytoplasmic RNAIBA 02/2024
1	Antinuclear AntibodiesIBA 01/2024
1	AntibodiesIBA 01/2024
1	AutoantibodiesIBA 01/2024
1	5-(tetradecyloxy)-2-furancarboxylic acid (TOFA)IBA 10/2023
1	Methotrexate (Mexate)FDA LinkGeneric 10/2023
1	tofacitinibIBA 10/2023
1	Janus Kinase InhibitorsIBA 10/2023
1	baricitinibIBA 10/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2023

Therapy/Procedure

22	Therapeutics 03/2024 - 11/2007
7	Drug Therapy (Chemotherapy) 05/2024 - 06/2017
5	Prostatectomy (Retropubic Prostatectomy) 12/2013 - 03/2008
4	Immunotherapy 02/2024 - 12/2018
3	Hematopoietic Stem Cell Transplantation 04/2024 - 11/2023
3	Radiotherapy 03/2024 - 01/2016
2	Neoadjuvant Therapy 05/2024 - 01/2021